Artificial Photo Synthesis
Artificial
photosynthesis as a chemical change reflects natural
photosynthesis to scale back anthropogenic CO2 (CO2), raise
fuel security, and supply a continuous global economy. Because of the event of some suitable technologies, we will promote artificial
photosynthesis using artificial leaves for the profitable conversion of solar power into H2 and other fuels. This practice may be a potential technology for H2 production by resembling natural
photosynthesis by green leaves. So, research has been carried out to accumulate
solar energy to contribute H2 by artificial photosynthesis. In artificial photosynthesis, the synthetic leaf must be ready to use sunlight and water to scale back CO2 and water into H2. Thus, artificial
photosynthesis has devised great interest owing to the utilization of photoelectrochemical
cells (PEC) to use sunlight to amount solar fuel. In process, solar-driven electrochemical
fuel generation needs the mixing of light-absorbing and electrochemical constituents ready to divide product fuels. Natural
photosynthesis synthesizes glucose and oxygen in the presence of sunlight. In the presence of sunlight, the excitation of chlorophyll
molecules in PSII and PSI develops ATP and NADPH along the ETC with the crisis of different protein complexes. Similarly, in artificial photosynthesis, the use of
solar energy to develop NADPH as an electron donor by PSI must be obtained.
High Impact List of Articles
-
Interview with Graham Clarke
Graham Clarke
Interview: Clinical Investigation
-
Interview with Graham Clarke
Graham Clarke
Interview: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Assessment and management of mucositis in head and neck cancer patients
Marcelo Bonomi, Nadia Camille, Krzysztof Misiukiewicz, Asma Latif, Vishal Gupta, Seth Blacksburg, Eric Genden,Marshall Posner
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessment and management of mucositis in head and neck cancer patients
Marcelo Bonomi, Nadia Camille, Krzysztof Misiukiewicz, Asma Latif, Vishal Gupta, Seth Blacksburg, Eric Genden,Marshall Posner
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical